Podcast
Outcomes Rocket
Hosted by Saul Marquez · EN
The Outcomes Rocket podcast brings you conversations with the healthcare leaders actually building the future of care. Hosted by Saul Marquez, founder and CEO of Outcomes Rocket and a 17 year medical device veteran.
Every episode goes deep with one operator: a health system executive, a medtech commercial leader, a health tech founder, a clinician, an investor. They talk about what they’re building, what broke along the way, and what they’d do differently.
With more than 2,000+ episodes in the archive, this is one of the largest libraries of healthcare leadership interviews anywhere. No fluff, no press release talk. Just people who’ve done the work telling you how they did it.
If you’re responsible for outcomes, revenue, or both, you’ll leave each episode with something you can use this week.
New episodes weekly.
[CLAIM:9UANJG7C]
105episodes
Episodes
Newest firstAll episodes
The Future of Medical Robotics: AI, Automation, and Global Growth with KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics
Jun 1500:06:12Tap to summarizeAI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shaping the future of medical robotics. While AI is becoming more prevalent in areas such as simulation, collision detection, and path planning, they emphasize that regulatory requirements limit its role in autonomous clinical decision-making. They also highlight KUKA's focus on quality, strategic partnerships, global expansion, and the development of new robotic platforms to support a growing range of medical applications. Tune in to hear how KUKA is navigating the opportunities and challenges of AI, automation, and innovation in healthcare robotics! Resources: Connect with and follow Silke Wendt on LinkedIn. Connect with and follow Corey Ryan on LinkedIn. Follow KUKA Robotics USA on LinkedIn and explore their website!
Transcribe →
How Health Economics Drives Medtech Growth with Christian Howell, CEO of Cognito Therapeutics
Jun 1100:15:39Tap to summarizeA non-invasive Alzheimer’s therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer’s therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito’s HOPE study, the largest non-pharmacologic clinical trial in neurodegenerative disease, involving 673 participants across 70 sites. Christian explains why a strong evidence strategy is essential not only for regulatory approval but also for reimbursement, clinical adoption, and patient access. He also reflects on leadership lessons centered on service, humility, humor, and the importance of aligning stakeholders across the healthcare ecosystem to improve Alzheimer’s care. Tune in to hear how Christian Howell and Cognito Therapeutics are working to bring new hope, stronger evidence, and a more accessible path forward for Alzheimer’s patients and families! Resources: Connect with and follow Christian Howell on LinkedIn. Follow Cognito Therapeutics on LinkedIn and explore their website.
Transcribe →
How Health Economics Drives Medtech Growth with Betty Tsai, President of Cardiology Services International
Jun 900:11:37Tap to summarizeHealth economics is not just about reimbursement. It is about proving how a technology reduces the total cost of care. In this episode, Betty Tsai, President of Cardiology Services International, explains why medtech companies must think beyond existing CPT or MS-DRG codes when shaping their commercialization strategies. Speaking with Saul at the MedTech Innovator event, she highlights how health economics reveals the true cost of a patient journey, from initial admission through readmissions and long-term care. Betty explores how value-based care and CMS performance metrics are reshaping hospital revenue and influencing adoption decisions. She also discusses alternative reimbursement pathways, such as the New Technology Add-on Payment, and emphasizes that companies demonstrating both clinical and economic value are more attractive to providers and investors. Tune in and learn why proving economic value may be one of the most important steps in driving medtech adoption. Resources: Connect with and follow Betty Tsai on LinkedIn.
Transcribe →
From One Event to a Global Platform: The Rise of MedTech World with Dr. Dylan Attard, CEO and Co-founder of MedTech World
Jun 400:08:52Tap to summarizeWhat started as a one-year break from surgery became a global medtech movement. In this episode, Dr. Dylan Attard, CEO and Co-founder of MedTech World, shares how his journey from surgical training to entrepreneurship led to the creation of MedTech World, now a global platform hosting events across Europe, Asia, the Middle East, and North America. What began as a single event in Malta has evolved into a multi-region ecosystem connecting startups, investors, and healthcare leaders. He highlights the strategic expansion into Florida, a growing yet underrecognized medtech hub, and emphasizes the importance of creating spaces where companies can raise capital and enter new markets. Dr. Attard also reflects on the personal “why” behind his work, sharing how exposure to cardiac innovations, especially after losing his father, reinforces the mission to accelerate life-saving technologies. Tune in to hear how Dr. Dylan Attard scaled MedTech World across continents, and the personal story driving his mission to accelerate life-saving innovation! Resources: Connect with and follow Dr. Dylan Attard on LinkedIn. Follow MedTech World on LinkedIn and explore their website!
Transcribe →
Building a scalable pharma launch engine that drives competitive advantage with Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait
Jun 200:26:11Tap to summarizeMost pharma launch frameworks don’t fail because they lack structure; they fail because they become rigid checklists that kill strategic thinking. In this episode, Lumanity’s Business Development Director, Jeff Hart, and Launch Excellence Principal, Kirsty Tait, talk about how pharmaceutical companies can scale launch excellence as pipelines grow and complexity increases. Kirsty and Jeff explain that rigid, one-size-fits-all frameworks lead to inefficiency, slow decisions, and misalignment across global and local teams. Instead, organizations need a standardized operating system with built-in flexibility to tailor strategy by asset and market. Ultimately, success depends not just on process, but on strong governance, a single source of truth, and a winning culture that drives execution. If your launch process feels slow, inconsistent, or overly complex, this conversation will help you rethink how to scale without losing speed or impact. Resources: Follow Lumanity on LinkedIn and explore their website! Connect with and follow Kirsty Tait on LinkedIn. Connect with and follow Jeff Hart on LinkedIn.Take a look at the Launch Excellence Health Check here! Learn more about this series we're doing with Lumanity here: https://lumanity.com/commercialization-podcasts/
Transcribe →
Reinventing Blood Testing for Better Patient Experience with Web Golinkin, President at Babson Diagnostics
May 2800:21:41Tap to summarizeWhat if the biggest barrier to better healthcare outcomes is… the blood draw itself? In this episode, Web Golinkin, President at Babson Diagnostics, discusses how his company is reinventing blood testing with a patient-friendly, fingertip-based system. He explains why traditional venipuncture drives anxiety and non-adherence, and how BetterWay improves both experience and outcomes. He also shares how automation and simplified workflows reduce operational burden and expand access points for care. Finally, he explores why patient experience is becoming the key competitive differentiator in ambulatory healthcare. Tune in to learn how rethinking a decades-old process could unlock better care, better business, and better patient engagement. Resources: Connect with and follow Web Golinkin on LinkedIn, visit his website, or reach out via email! Follow Babson Diagnostics on LinkedIn and explore their website! Learn more about BetterWay here!
Transcribe →
From Innovation to Adoption: What It Really Takes to Win in Medtech with Ken Nelson, Partner and Founder at Nelson Jennings Ventures
May 2800:06:36Tap to summarizeGreat medtech innovations win because patients actually use them. In this episode, Ken Nelson, Partner and Founder at Nelson Jennings Ventures, shares his journey from cardiac device sales at Boston Scientific to helping commercialize major players in cardiac monitoring, including iRhythm, BioTelemetry, and Bardy Diagnostics. He highlights how innovations such as wearable cardiac patches have transformed patient adoption and reshaped the monitoring market. Ken reflects on Medtech Innovator's impact in accelerating commercialization, partnerships, and investor readiness. He advises early-stage companies to leverage accelerators and industry events like Life Science Intelligence to strengthen their path to market and fundraising success. Tune in to hear how decades of experience in cardiac monitoring and startup scaling translate into practical advice for founders navigating commercialization and growth! Resources: Connect with and follow Ken Nelson on LinkedIn.
Transcribe →
Shifting from Denial Management to Denial Prevention with Jason Considine, President of Experian Health
May 2700:21:54Tap to summarizeSimplifying the complex world of healthcare reimbursement. In this episode, Jason Considine, President of Experian Health, discusses shifting the industry's focus from denial management to denial prevention by leveraging AI at the point of registration. He discusses the implementation of the Patient Access Curator, a tool that automates insurance discovery and validation to reduce human error and administrative costs. He also explains how Experian leverages rich data assets, such as employment data, to help providers navigate new regulatory requirements, such as the OBBA. This episode explores the mission of leveraging advanced technology to eliminate administrative waste, enabling resources to be redeployed into direct patient care. Tune in to start from the start with denial prevention! Resources Connect with and follow Jason Considine on LinkedIn. Follow Experian Health on LinkedIn and explore their website.
Transcribe →
Building Trustworthy AI in Healthcare with Dr. Peter Bonis, Chief Medical Officer at Wolters Kluwer Health
May 2600:16:40Tap to summarizeAI is advancing rapidly in healthcare, but speed without governance can create serious clinical, legal, and enterprise-level risks. In this episode, Peter Bonis, MD, Chief Medical Officer at Wolters Kluwer Health, explores how his team is developing reliable, evidence-based AI tools to support frontline clinicians without compromising trust or safety. He explains why clinicians are adopting AI faster than health systems can govern it, creating risks like the rise of “shadow AI.” Peter highlights the importance of transparency, human oversight, and trusted source material in ensuring safe clinical decision support. He also discusses how even experts can be influenced by faulty AI output and why governance models must evolve with frontline input to keep pace. Tune in and learn how healthcare leaders can approach AI governance more responsibly while still supporting innovation at the point of care! Resources: Connect with and follow Dr. Peter Bonis on LinkedIn! Follow Walters Kluwer Health on LinkedIn and visit their website!
Transcribe →
Designing for the End: Bridging Medtech Development and Manufacturing with Amanda Helgeson, Business Development Manager at Forj Medical
May 2600:09:14Tap to summarizeMost medtech startups fail before market. The ones that succeed? They plan for it from day one. In this episode, Amanda Helgeson, Business Development Manager at Forj Medical, discusses her work at the CDMO, which helps medtech startups navigate the critical transition from development to manufacturing. She notes that standout companies at Medtech Innovator pair meaningful clinical innovation with the passion and persistence needed to reach the market. Forj differentiates itself by integrating design and manufacturing early, helping companies avoid costly downstream issues. Her core message is to take a holistic, long-term approach, aligning product design, regulatory pathways, and reimbursement strategies from the outset while staying flexible to adapt. Tune in to learn how a holistic, future-focused approach can turn promising ideas into scalable medical devices! Resources: Connect with and follow Amanda Helgeson on LinkedIn. Follow Forj Medical on LinkedIn and explore their website!
Transcribe →